Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 621–636.
Smith EM, Cadet P, Stefano GB, Opp MR, Hughes TK Jr. IL-10 as a mediator in the HPA axis and brain. J Neuroimmunol 1999; 100: 140–148.
Weiler JM. Introduction. In: Whaley K, Loos M, Weiler JM (eds). Complement in health and disease, 2nd edn. Kluwer Academic Publishers, Dordrecht, Boston, London, 1993, pp 1–37.
Takabayashi T, Vannier E, Clark BD, et al. A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. J Immunol 1996; 156: 3455–3460.
Ertel W, Morrison MH, Ayala A, Chaudry IH. Hypoxemia in the absence of blood loss or significant hypotension causes inflammatory cytokine release. Am J Physiol 1995; 269: R160–R166.
Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066–1071.
Dinarello CA. Proinflammatory cytokines. Chest 2000; 118: 503–508.
Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002; 966: 290–303.
Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol 1998; 274: R577–R595.
Luheshi GN, Stefferl A, Turnbull AV, et al. Febrile response to tissue inflammation involves both peripheral and brain IL-1 and TNF-alpha in the rat. Am J Physiol 1997; 272: R862–R868.
Heuertz RM, Webster RO. Role of C-reactive protein in acute lung injury. Mol Med Today 1997; 3: 539–545.
Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997; 18: 428–432.
Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994; 179: 1695–1699.
Rennick D, Berg D, Holland G. Interleukin 10: an overview. Prog Growth Factor Res 1992; 4: 207–227.
Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. Faseb J 1994; 8: 504–512.
Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343: 831–836.
Leist M, Nicotera P. The shape of cell death. Biochem Biophys Res Commun 1997; 236: 1–9.
Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445–1449.
Larrick JW, Wright SC. Cytotoxic mechanism of tumor necrosis factor-alpha. Faseb J 1990; 4: 3215–3223.
Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103: 565–575.
Royall JA, Berkow RL, Beckman JS, Cunningham MK, Matalon S, Freeman BA. Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability. Am J Physiol 1989; 257: L399–L410.
Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 1999; 27: 1262–1264.
Hövels-Gürich HH, Schumacher K, Vazquez-Jimenez JF, et al. Cytokine balance in infants undergoing cardiac operation. Ann Thorac Surg 2002; 73: 601–608; discussion 608–609.
Qing M, Vazquez-Jimenez JF, Klosterhalfen B, et al. Influence of temperature during cardiopulmonary bypass on leukocyte activation, cytokine balance, and post-operative organ damage. Shock 2001; 15: 372–377.
Vazquez-Jimenez JF, Qing M, Hermanns B, et al. Moderate hypothermia during cardiopulmonary bypass reduces myocardial cell damage and myocardial cell death related to cardiac surgery. J Am Coll Cardiol 2001; 38: 1216–1223.
van Deventer SJ. Cytokine and cytokine receptor polymor- phisms in infectious disease. Intensive Care Med 2000; 26: S98–S102.
Verthelyi D, Klinman DM. Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo. Immunology 2000; 100: 384–390.
Ma Qing, Schumacher K, Heise R, et al. Intramyocardial synthesis of pro- and anti-inflammatory cytokines in infants with congenital cardiac defects. J Am Coll Cardiol (in press).
Ferreiro CR, Chagas AC, Carvalho MH, et al. Influence of hypoxia on nitric oxide synthase activity and gene expression in children with congenital heart disease: a novel pathophysiological adaptive mechanism. Circulation 2001; 103: 2272–2276.
Tabardel Y, Duchateau J, Schmartz D, et al. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 1996; 119: 76–80.
Suberville S, Bellocq A, Fouqueray B, et al. Regulation of interleukin-10 production by beta-adrenergic agonists. Eur J Immunol 1996; 26: 2601–2605.
Corbel M, Germain N, Lanchou J, et al. The selective phosphodiesterase 4 inhibitor RP 73–401 reduced matrix metalloproteinase 9 activity and transforming growth factor-beta release during acute lung injury in mice: the role of the balance between Tumor necrosis factor-alpha and interleukin-10. J Pharmacol Exp Ther 2002; 301: 258–265.
Wolk K, Docke W, von Baehr V, Volk H, Sabat R. Comparison of monocyte functions after LPS- or IL-10-induced reorientation: importance in clinical immunoparalysis. Pathobiology 1999; 67: 253–256.
Adib-Conquy M, Asehnoune K, Moine P, Cavaillon JM. Long-term-impaired expression of nuclear factor-kappa B and I kappa B alpha in peripheral blood mononuclear cells of trauma patients. J Leukoc Biol 2001; 70: 30–38.
Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation – rationale for a new therapeutic strategy in sepsis. Intensive Care Med 1996; 22: S474–S480.
Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497–503.
Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845–857.
Hammerschmidt DE, Stroncek DF, Bowers TK, et al. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 81: 370–377.
Kirklin JK, Chenoweth DE, Naftel DC, et al. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Ann Thorac Surg 1986; 41: 193–199.
Tanaka K, Takao M, Yada I, Yuasa H, Kusagawa M, Deguchi K. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth 1989; 3: 181–188.
Fung M, Loubser PG, Undar A, et al. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. J Thorac Cardiovasc Surg 2001; 122: 113–122.
Meri S, Aronen M, Leijala M. Complement activation during cardiopulmonary bypass in children. Complement 1988; 5: 46–54.
Seghaye MC, Duchateau J, Grabitz RG, et al. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 1993; 106: 978–987.
Seghaye MC, Duchateau J, Grabitz RG, et al. Complement, leukocytes, and leukocyte elastase in full-term neonates undergoing cardiac operation. J Thorac Cardiovasc Surg 1994; 108: 29–36.
Vaage J, Valen G. Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery. A review. Scand J Thorac Cardiovasc Surg Suppl 1993; 41: 1–18.
Tassani P, Barankay A, Haas F, et al. Cardiac surgery with deep hypothermic circulatory arrest produces less systemic inflammatory response than low-flow cardiopulmonary bypass in newborns. J Thorac Cardiovasc Surg 2002; 123: 648–654.
Wilson I, Gillinov AM, Curtis WE, et al. Inhibition of neutrophil adherence improves postischemic ventricular performance of the neonatal heart. Circulation 1993; 88: II372–II379.
Seghaye MC, Duchateau J, Grabitz RG, et al. Histamine liberation related to cardiopulmonary bypass in children: possible relation to transient postoperative arrhythmias. J Thorac Cardiovasc Surg 1996; 111: 971–981.
McBride WT, Armstrong MA, Gilliland H, McMurray TJ. The balance of pro and anti-inflammatory cytokines in plasma and bronchoalveolar lavage (BAL) at paediatric cardiac surgery. Cytokine 1996; 8: 724–729.
Seghaye M, Duchateau J, Bruniaux J, et al. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg 1996; 111: 545–553.
Journois D, Israel-Biet D, Pouard P, et al. High-volume, zero- balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 1996; 85: 965–976.
Tarnok A, Hambsch J, Schneider P. Cardiopulmonary bypass-induced increase of serum interleukin-10 levels in children. J Thorac Cardiovasc Surg 1998; 115: 475–477.
Jansen NJ, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CR. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 744–747; discussion 747–748.
Metinko AP, Kunkel SL, Standiford TJ, Strieter RM. Anoxia-hyperoxia induces monocyte-derived interleukin-8. J Clin Invest 1992; 90: 791–798.
Gormley SM, McBride WT, Armstrong MA, et al. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass. Cytokine 2002; 17: 61–65.
Seghaye MC, Grabitz RG, Duchateau J, et al. Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations. J Thorac Cardiovasc Surg 1996; 112: 687–697.
Simpson J, Stephenson T. Regulation of extracellular fluid volume in neonates. Early Hum Dev 1993; 34: 179–190.
Hövels-Gürich HH, Vazquez-Jimenez JF, Silvestri A, et al. Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of great arteries. J Thorac Cardiovasc Surg 2002; 124: 811–820.
Levi R, Zavecz JH. Acceleration of idioventricular rhythms by histamine in guinea pig heart: mediation by H2 receptors. Circ Res 1979; 44: 847–855.
Levi R, Owen DAA, Trzeciakowski J. Actions of Histamine on the heart and vasculature. In: Granellin CR, Parsons ME (eds). Pharmacology of histamine receptors. Wright, PSG, Bristol, London, Boston, 1998, pp 236–297.
Grant JW, Serwer GA, Armstrong BE, Oldham HN, Anderson PA. Junctional tachycardia in infants and children after open heart surgery for congenital heart disease. Am J Cardiol 1987; 59: 1216–1218.
Martin D, Lown B. Is amiodarone good for heartburn? Arch Intern Med 1990; 150: 1345–1347.
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864–874.
Kalfin RE, Engelman RM, Rousou JA, et al. Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation 1993; 88: II401–II406.
Seghaye MC, Duchateau J, Grabitz RG, et al. Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: a clinical and experimental study. J Thorac Cardiovasc Surg 1996; 111: 882–892.
Tassani P, Kunkel R, Richter JA, et al. Effect of C1-esterase-inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates. J Cardiothorac Vasc Anesth 2001; 15: 469–473.
Rioux P. TP-10 (AVANT Immunotherapeutics). Curr Opin Investig Drugs 2001; 2: 364–371.
Videm V, Mollnes TE, Fosse E, et al. Heparin-coated cardiopulmonary bypass equipment I. Biocompatibility markers and development of complications in a high-risk population. J Thorac Cardiovasc Surg 1999; 117: 794–802.
Miyaji K, Hannan RL, Ojito J, Jacobs JP, White JA, Burke RP. Heparin-coated cardiopulmonary bypass circuits: clinical effects in pediatric cardiac surgery. J Card Surg 2000; 15: 194–198.
Watanabe H, Miyamura H, Hayashi J, et al. The influence of a heparin-coated oxygenator during cardiopulmonary bypass on postoperative lung oxygenation capacity in pediatric patients with congenital heart anomalies. J Card Surg 1996; 11: 396–401.
Murkin JM. Cardiopulmonary bypass and the inflammatory response: a role for serine protease inhibitors? J Cardiothorac Vasc Anesth 1997; 11: 19–23; discussion 24–25.
Seghaye MC, Duchateau J, Grabitz RG, et al. Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children. Ann Thorac Surg 1996; 61: 1205–1211.
Sisto T, Paajanen H, Metsa-Ketela T, Harmoinen A, Nordback I, Tarkka M. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann Thorac Surg 1995; 59: 1519–1523.
Andersen LW, Thiis J, Kharazmi A, Rygg I. The role of N-acetylcystein administration on the oxidative response of neutrophils during cardiopulmonary bypass. Perfusion 1995; 10: 21–26.
Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric open heart operations. Ann Thorac Surg 1993; 56: 1518–1522.
Bokesch PM, Kapural MB, Mossad EB, et al. Do peritoneal catheters remove pro-inflammatory cytokines after cardiopulmonary bypass in neonates? Ann Thorac Surg 2000; 70: 639–643.
Bronicki RA, Backer CL, Baden HP, Mavroudis C, Crawford SE, Green TP. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 2000; 69: 1490–1495.
Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa B and the heart. J Am Coll Cardiol 2001; 38: 307–314.
Wong SC, Fukuchi M, Melnyk P, Rodger I, Giaid A. Induction of cyclooxygenase-2 and activation of nuclear factor-kappa B in myocardium of patients with congestive heart failure. Circulation 1998; 98: 100–103.